Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis

Conclusion: Crisaborole demonstrated a favorable efficacy and safety profile in both treatment-experienced and TN patients. ClinicalTrials.gov, NCT02118766 and NCT02118792.PMID:38206678 | DOI:10.1089/derm.2023.0112

Source: Dermatitis - January 11, 2024 Category: Dermatology Authors: Linda F Stein Gold Wynnis L Tom Vivian Shi Paul Sanders Chuanbo Zang Bonnie Vlahos Amy Cha Source Type: research